K

Kamalakshamma

Active Director Director DIN 11250638
DIN 11250638 First appointment Aug 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Kamalakshamma

Data last updated:

Kamalakshamma is a Director at Tanu Lifesciences Private Limited (since 2025). The company operates in Pharma.

DIN 11250638
Primary Designation Director
Industry Pharma
First Appointment 20 Aug 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Tanu Lifesciences Private Limited U68100KA2025PTC206837
Director20 Aug 20252025Active

Board colleagues of Kamalakshamma

NameDINCompanyDesignation
Hamsini Shivanand11289636Tanu Lifesciences Private LimitedAdditional Director
Siddaramaiah Geetha11250639Tanu Lifesciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Tanu Lifesciences Private Limited
Premium access

Shareholding and investment profile for Kamalakshamma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kamalakshamma

Kamalakshamma currently holds 1 directorship: Tanu Lifesciences Private Limited (Director, since 20 Aug 2025).

Kamalakshamma was first appointed on 20 Aug 2025 as Director at Tanu Lifesciences Private Limited.

The current boards of Kamalakshamma's companies include Hamsini Shivanand (Tanu Lifesciences Private Limited), Siddaramaiah Geetha (Tanu Lifesciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available